Re: A Wing and a Prayer
|
15
|
Resverlogix Corp.
|
Sep 20, 2019 09:36PM
|
Re: AHA Late Breaker!
|
|
Resverlogix Corp.
|
Sep 20, 2019 04:23PM
|
Re: AHA Late Breaker!
|
5
|
Resverlogix Corp.
|
Sep 20, 2019 02:18PM
|
Re: AHA Late Breaker!
|
3
|
Resverlogix Corp.
|
Sep 20, 2019 01:08PM
|
Re: AHA Late Breaker!
|
4
|
Resverlogix Corp.
|
Sep 20, 2019 12:32PM
|
AHA Late Breaker!
|
11
|
Resverlogix Corp.
|
Sep 20, 2019 11:58AM
|
Re: AHA late breakers....
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 04:46PM
|
Re: Third Eye, AHA, US Listing
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 10:44AM
|
Re: Third Eye, AHA, US Listing
|
6
|
Resverlogix Corp.
|
Sep 19, 2019 10:08AM
|
Re: Third Eye, AHA, US Listing
|
5
|
Resverlogix Corp.
|
Sep 19, 2019 06:47AM
|
Re: BIO CEO Slides Up
|
5
|
Resverlogix Corp.
|
Sep 18, 2019 05:21PM
|
Re: Total Patient Hours Question
|
3
|
Resverlogix Corp.
|
Sep 17, 2019 10:25PM
|
Re: Total Patient Hours Question
|
5
|
Resverlogix Corp.
|
Sep 17, 2019 09:18PM
|
Re: 2019 Potential Events
|
7
|
Resverlogix Corp.
|
Sep 17, 2019 10:55AM
|
Re: EASD 2019 Sept 16-20, 2019
|
7
|
Resverlogix Corp.
|
Sep 17, 2019 09:56AM
|
MD&A and Financials Sept 16, 2019
|
4
|
Resverlogix Corp.
|
Sep 16, 2019 09:08PM
|
Re: Total Patient Hours Question
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 05:43PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 04:22PM
|
BIO Investor Forum, Oct 22-23
|
6
|
Zenith Epigenetics
|
Sep 16, 2019 04:17PM
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 04:11PM
|